Outset Medical (NASDAQ:OM – Get Rating) had its price target decreased by stock analysts at Cowen from $60.00 to $33.00 in a research note issued to investors on Tuesday, Stock Target Advisor reports. The brokerage presently has an “outperform” rating on the stock. Cowen’s price target points to a potential upside of 126.65% from the […]
Outset Medical (NASDAQ:OM – Get Rating) and Hyperfine (NASDAQ:HYPR – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership. Institutional and Insider Ownership 22.7% of Hyperfine shares are owned […]
Outset Medical, Inc. (NASDAQ:OM – Get Rating) CEO Leslie Trigg sold 65,000 shares of the company’s stock in a transaction on Friday, April 1st. The stock was sold at an average price of $46.18, for a total transaction of $3,001,700.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can […]
Outset Medical, Inc. (NASDAQ:OM – Get Rating) COO Martin Vazquez sold 1,030 shares of the firm’s stock in a transaction dated Wednesday, March 16th. The shares were sold at an average price of $39.77, for a total value of $40,963.10. The sale was disclosed in a legal filing with the SEC, which is accessible through […]
Outset Medical (NASDAQ:OM – Get Rating) and Precision Optics (OTCMKTS:PEYE – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk. Valuation & Earnings This table compares Outset Medical and […]